Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2024-05-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Massive Rotator Cuff Tendon Tear Treatment.
NCT06016439
Rotator Cuff Failure With Continuity
NCT02716441
Arthroscopic Rotator Cuff Repair: Suture Anchors Versus Arthroscopic Transosseous Fixation
NCT01815177
Rotator Cuff Tears Treated With Long Head of the Biceps Reinforcement
NCT06664645
Superior Capsular Reconstruction Versus. Partial Repair for Irreparable Rotator Cuff Tears
NCT04584476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tissue engineering is a promising strategy that would combine modern engineering techniques with novel biomaterials, cell therapy, growth factors, bioactive molecular. Enhancement of BTI healing with biomaterial, such as magnesium, may promote osteogenesis and thus improve the surgical outcome. These various approaches have been investigated in pre-clinical animal models of rotator cuff repair, yet further investigation to translate these into clinical practice is needed (8).
We have developed a magnesium pin that can be applied to the cuff repair site to improve the BTI healing.
The use of biodegradable materials as implants to stimulate healing has been developed in orthopaedics for decades. Our team and others reported that Mg-based interference screw or suture anchors could upregulate the expression of osteogenic and angiogenic factors experimentally, yet further investigation is still required to translate into clinical practice. However, the potential insufficient mechanical strength of Mg-based implants over the degradation period may result in a loss of fixation or failure of repair, which limits its clinical application. Herein, our novel magnesium pin showed good mechanical properties to be used to enhance the suture anchor commonly used for RCT repair in clinical practice. This can incorporate the benefit of an Mg-based component for its degradation and release of osteogenic and angiogenic by-products, but without the risk of compromising the integrity of the RCT repair site or the potentially osteoporotic bone at the repair site.
40 patients with rotator cuff tear scheduled for arthroscopic rotator cuff repair (ARCR) will be recruited from the Li Ka Shing Orthopaedic Specialist clinic at the Prince of Wales Hospital (PWH) Hong Kong.
Oral and written consents will be obtained from individuals who agree to participate in the study.
The recruitment period will last for 12 months and the whole project period is 2 years in total. Basic demographics, MRI assessment and Outcome Measurement Questionnaires will be carried out.
The intervention groups receive treated using magnesium pin in additional to the suture anchor used routinely in clinical practice, whereas the control group receives routine suture anchor for the treatment-as-usual (TAU). Both treatments are conducted in clinical practices that are randomly allocated to either the intervention or the control condition. Participants are therefore randomized as their allocation depends on their practice being an intervention or a control practice.
Assessments including anthropometric measurement, range of motion, shoulder muscle strength assessment, inflammation test and questionnaires will be conducted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
The intervention groups receives treated using magnesium pin in additional to the suture anchor used routinely in clinical practice.
magnesium pin in additional to the suture anchor
magnesium pin in additional to the suture anchor used routinely in clinical practice
Control group
The control group receives routine suture anchor for the treatment-as-usual (TAU).
routine suture anchor
routine suture anchor for the treatment-as-usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
magnesium pin in additional to the suture anchor
magnesium pin in additional to the suture anchor used routinely in clinical practice
routine suture anchor
routine suture anchor for the treatment-as-usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is \> 40 years of age (no upper limit);
* Subject provides written informed consent for study participation using an Independent Ethical Committee (IEC) / Institutional Review Board (IRB) approved consent form;
* Subject is willing and able to participate in required follow-up visits and is able to complete study activities.
Exclusion Criteria
* Subjects with Samilson-Prieto osteoarthritis \> 2;
* Subjects with current or prior infection of the ipsilateral shoulder;
* Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, or chronic joint disease;
* Subjects with prior shoulder surgery (not including rotator cuff repair (revision repair subject group only), biceps tenodesis/tenotomy, distal clavicle excision (DCE), ubacromial decompression);
* Subjects with an irreparable or partially reparable rotator cuff tear;
* Subjects with a subscapularis tear requiring repair;
* Subjects requiring a concomitant labral fixation procedure;
* Subjects requiring a concomitant os acromiale fixation procedure
* Subjects with glenohumeral joint instability (multiple dislocations/subluxations);
* Subjects with a subacromial or intra-articular injection within 3 months prior to surgery;
* Subjects with condition(s) that contraindicate or complicate outcomes of ARCR e.g., \> Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy \> Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head or glenoid, history of immunodeficiency disorders, history of chronic inflammatory disorders, oral or injected steroid use in last 4 weeks;
* Pregnancy or possibility of pregnancy
* Patient's inability to understand written and spoken Chinese, Mandarin or English.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Tim-Yun Michael ONG
Clinical Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Chinese University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023.211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.